×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Neximmune Inc. (NEXI) NASDAQ

$5.61 0.10 (1.81%)

Market Cap: $77.71M

As of 03/28/24 04:00 PM EDT. Market closed.

(NEXI)

Neximmune Inc. (NEXI)
NASDAQ

$5.61
0.10 (1.81%)

Market Cap: $77.71M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

neximmune is an emerging biopharmaceutical company advancing a new generation of immunotherapies based on our proprietary aim™ technology. this nanotechnology platform, originally developed at johns hopkins university, is the foundation for an innovative approach to immunotherapy in which the body’s own immune system is stimulated to orchestrate a targeted t cell response against a disease. ... read more

neximmune is an emerging biopharmaceutical company advancing a new generation of immunotherapies based on our proprietary aim™ technology. this nanotechnology platform, originally developed at johns hopkins university, is the foundation for an innovative approach to immunotherapy in which the body’s own immune system is stimulated to orchestrate a targeted t cell response against a disease. central to the aim technology are artificial antigen presenting cells (aapc) that present antigens to t cells eliciting a highly targeted therapy driven by the patient’s immune system. these aapc can be rapidly engineered to elicit a specific immune attack that can be directed toward any foreign substance or cell type in a patient’s body. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Address
.
PRICE CHART FOR NEXIMMUNE INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$5.51
Days Range
$5.51 - $5.70
52 week range
$1.25 - $28.69
Volume
12,553
Avg. Volume (30 days)
97,908
Market Cap
$77.71M
Dividend Yield
-
P/E
-
Shares Outstanding
13,852,870
Open
-
Previous Close
$5.51
Days Range
$5.51 - $5.70
52 week range
$1.25 - $28.69
Volume
12,553
Avg. Volume (30 days)
97,908
Market Cap
$77.71M
Dividend Yield
-
P/E
-
Shares Outstanding
13,852,870
FINANCIAL STATEMENTS FOR NEXIMMUNE INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR NEXIMMUNE INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
BARER SOL JDirectorMar 30, 2023 Buy$0.41400,000164,1202,217,814Mar 31, 2023, 04:56 PM
BARER SOL JDirectorNov 16, 2022 Buy$0.48125,00060,3001,742,814Nov 17, 2022, 08:40 PM
BARER SOL JDirectorNov 17, 2022 Buy$0.4875,00035,9171,817,814Nov 17, 2022, 08:40 PM
Verstandig GrantDirectorJun 06, 2022 Buy$2.1425,00053,5371,078,619Jun 07, 2022, 06:17 PM
Verstandig GrantDirectorJun 07, 2022 Buy$2.2826,87661,3851,105,495Jun 07, 2022, 06:17 PM
Verstandig GrantDirectorJun 03, 2022 Buy$2.2215,00033,3741,053,619Jun 07, 2022, 06:17 PM
Verstandig GrantDirectorMay 31, 2022 Buy$2.1145,02495,118950,519Jun 02, 2022, 07:42 PM
Verstandig GrantDirectorJun 01, 2022 Buy$2.3840,20095,760990,719Jun 02, 2022, 07:42 PM
Verstandig GrantDirectorJun 02, 2022 Buy$2.2347,900106,6831,038,619Jun 02, 2022, 07:42 PM
BARER SOL JDirectorJun 01, 2022 Buy$2.3540,00094,1601,597,094Jun 02, 2022, 07:41 PM
BARER SOL JDirectorJun 02, 2022 Buy$2.2220,72046,1001,617,814Jun 02, 2022, 07:41 PM
BARER SOL JDirectorMay 31, 2022 Buy$2.1939,28085,8941,557,094Jun 02, 2022, 07:41 PM
Jones KristiPresident and CEOMar 29, 2022 Buy$3.7410,00037,40073,078Mar 30, 2022, 07:57 PM
Verstandig GrantDirectorMar 28, 2022 Buy$3.7618,98371,376905,495Mar 28, 2022, 04:15 PM
Verstandig GrantDirectorMar 25, 2022 Buy$4.14131,622544,915886,512Mar 28, 2022, 04:15 PM
Verstandig GrantDirectorMar 24, 2022 Buy$3.3539,995133,983754,890Mar 28, 2022, 04:15 PM
BARER SOL JDirectorMar 23, 2022 Buy$2.6710,00026,6531,517,814Mar 24, 2022, 04:15 PM
BARER SOL JDirectorMar 22, 2022 Buy$2.4130,00072,3001,507,814Mar 23, 2022, 04:15 PM
BARER SOL JDirectorMar 21, 2022 Buy$2.1430,00064,0801,477,814Mar 22, 2022, 04:15 PM
BARER SOL JDirectorMar 18, 2022 Buy$2.1130,00063,2101,447,814Mar 21, 2022, 04:10 PM
Roemer Alan S.DirectorDec 21, 2021 Option Exercise$3.6367,657245,867195,641Dec 22, 2021, 05:00 PM
BARER SOL JDirectorDec 21, 2021 Option Exercise$5.1750,000258,5001,417,814Dec 22, 2021, 08:00 AM
Trainer JohnChief Financial OfficerJul 08, 2021 Option Exercise$5.173,43217,74361,770Jul 09, 2021, 04:19 PM
Trainer JohnChief Financial OfficerMay 08, 2021 Option Exercise$5.173,43217,74354,906May 19, 2021, 04:16 PM
Trainer JohnChief Financial OfficerApr 08, 2021 Option Exercise$5.173,43217,74351,474May 19, 2021, 04:16 PM
Trainer JohnChief Financial OfficerMar 10, 2021 Option Exercise$5.173,43217,74348,042Mar 12, 2021, 02:00 PM
Jones KristiChief Operating OfficerFeb 17, 2021 Buy$17.0091115,48763,078Feb 19, 2021, 04:30 PM
ZELDIS JEROME BExecutive VP of Research & DevFeb 17, 2021 Buy$17.005,88299,9945,882Feb 19, 2021, 04:30 PM
Verstandig GrantDirectorFeb 17, 2021 Buy$17.00175,0002,975,000714,895Feb 19, 2021, 04:25 PM
BARER SOL JDirectorFeb 17, 2021 Buy$17.0060,0001,020,0001,538,013Feb 19, 2021, 04:20 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
BARER SOL JDirector03/30/2023164,120
BARER SOL JDirector11/16/202260,300
BARER SOL JDirector11/17/202235,917
Verstandig GrantDirector06/06/202253,537
Verstandig GrantDirector06/07/202261,385
Verstandig GrantDirector06/03/202233,374
Verstandig GrantDirector05/31/202295,118
Verstandig GrantDirector06/01/202295,760
Verstandig GrantDirector06/02/2022106,683
BARER SOL JDirector06/01/202294,160
BARER SOL JDirector06/02/202246,100
BARER SOL JDirector05/31/202285,894
Jones KristiPresident and CEO03/29/202237,400
Verstandig GrantDirector03/28/202271,376
Verstandig GrantDirector03/25/2022544,915
Verstandig GrantDirector03/24/2022133,983
BARER SOL JDirector03/23/202226,653
BARER SOL JDirector03/22/202272,300
BARER SOL JDirector03/21/202264,080
BARER SOL JDirector03/18/202263,210
Roemer Alan S.Director12/21/2021245,867
BARER SOL JDirector12/21/2021258,500
Trainer JohnChief Financial Officer07/08/202117,743
Trainer JohnChief Financial Officer05/08/202117,743
Trainer JohnChief Financial Officer04/08/202117,743
Trainer JohnChief Financial Officer03/10/202117,743
Jones KristiChief Operating Officer02/17/202115,487
ZELDIS JEROME BExecutive VP of Research & Dev02/17/202199,994
Verstandig GrantDirector02/17/20212,975,000
BARER SOL JDirector02/17/20211,020,000
Load More Insider Transactions
FUNDS WITH A POSITION IN NEXIMMUNE INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
ADAGE CAPITAL PARTNERS GP, L.L.C.801,3710.00038%ExitedOther
GEODE CAPITAL MANAGEMENT, LLC108,1430%ExitedOther
RENAISSANCE TECHNOLOGIES LLC65,5000.00002%ExitedOther
ADAGE CAPITAL PARTNERS GP, L.L.C.32,0540.00015%NewOther
BLACKROCK INC.3600%ExitedOther
BLACKROCK INC.140%NewOther
CHANGE IN SHARES OUTSTANDING FOR NEXIMMUNE INC
STOCK BUYBACKS FOR NEXIMMUNE INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
0.45%
1Q
09/30/2023
03/31/2023
0.45%
2Q
09/30/2023
12/31/2022
0.39%
3Q
09/30/2023
09/30/2022
7.32%
4Q
09/30/2023
06/30/2022
14.54%
5Q
09/30/2023
03/31/2022
14.71%
6Q
09/30/2023
12/31/2021
15.21%
7Q
09/30/2023
09/30/2021
15.64%
8Q
09/30/2023
06/30/2021
15.87%
9Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
0.45%
1Q
03/31/2023
0.45%
2Q
12/31/2022
0.39%
3Q
09/30/2022
7.32%
4Q
06/30/2022
14.54%
5Q
03/31/2022
14.71%
6Q
12/31/2021
15.21%
7Q
09/30/2021
15.64%
8Q
06/30/2021
15.87%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR NEXIMMUNE INC
LOADING...